Dose-response relationships for human tumors: Implications for clinical trials of dose modifying agents
- 1 September 1984
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 10 (9) , 1703-1707
- https://doi.org/10.1016/0360-3016(84)90532-7
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Results of the phase I trial of the hypoxic cell radiosensitizer SR 2508International Journal of Radiation Oncology*Biology*Physics, 1984
- Nitroakridin 3582: a fluorescent nitroacridine stain for identifying hypoxic cellsThe British Journal of Radiology, 1983
- The potential benefit from a perfect radiosensitizer and its dependence on reoxygenationThe British Journal of Radiology, 1982
- Results of radical radiotherapeutic treatment of carcinoma of the pyriform sinus: Experience of the Institut CurieInternational Journal of Radiation Oncology*Biology*Physics, 1982
- The dose—time relationship in the radiotherapy of carcinoma of the cervix uteri: An application of the CRE formalismClinical Radiology, 1979
- Relation between time-dose and local control of operable breast cancer treated by tumorectomy and radiotherapy or by radical radiotherapy aloneCancer, 1978
- Clinical testing of the radiosensitizer Ro 07-0582: Experience with multiple dosesBritish Journal of Cancer, 1977
- First results of a randomized clinical trial of fast neutrons compared with X or gamma rays in treatment of advanced tumours of the head and neck. Report to the Medical Research Council.BMJ, 1975
- The number of patients required in a clinical trialThe British Journal of Radiology, 1971
- Carcinoma of the Cervix Treated by External Irradiation AloneRadiology, 1970